Susceptibility of Streptococcus agalactiae to erythromycin and clindamycin in pregnant women in the prenatal screening

Authors

  • Max Roberto Batista Araújo Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil. http://orcid.org/0000-0002-3293-8496
  • Poliane Vieira Reis Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.
  • Patrícia Helena Nascimento Bicalho Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.
  • Luisa Ferreira Seabra Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.

DOI:

https://doi.org/10.22491/2357-9730.85574

Keywords:

Streptococcus agalactiae, erythromycin, clindamycin, prenatal care, drug resistance, microbial

Abstract

Introduction: Group B streptococcus (GBS), or Streptococcus agalactiae, is a bacterium found in normal human microbiota. However, it may cause neonatal pneumonia, sepsis, and meningitis. Genital colonization in pregnant women is associated with a higher risk of preterm birth. The treatment of choice is antibiotic therapy with beta-lactams, but in the case of multidrug-resistance, erythromycin and clindamycin can be used.

 

Methods: This study evaluated bacterial cultures in the period from 2014 to 2015 from a group of 29,875 pregnant women. GBS colonization and resistance to erythromycin and clindamycin were investigated. Results: Positive cultures were found in 26.8% and 26.1% of the samples in 2014 and 2015, respectively. Levels of resistance to erythromycin and clindamycin were, respectively, 2.4% and 5.5% in 2014 and 3.2% and 6.5% in 2015. Conclusion: The investigation of GBS colonization and the evaluation of GBS resistance to erythromycin and clindamycin are of extreme relevance, given the increasing incidence of bacterial resistance, risks of preterm birth, and serious consequences to newborns, representing a global health problem.   Keywords: Streptococcus agalactiae; erythromycin; clindamycin; prenatal care; drug resistance, microbial

Downloads

Download data is not yet available.

Author Biographies

Max Roberto Batista Araújo, Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.

Setor de Microbiologia. Núcleo Técnico Operacional.

Poliane Vieira Reis, Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.

Setor de Microbiologia. Núcleo Técnico Operacional.

Patrícia Helena Nascimento Bicalho, Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.

Setor de Microbiologia. Núcleo Técnico Operacional.

Luisa Ferreira Seabra, Núcleo Técnico Operacional, Setor de Microbiologia, Instituto Hermes Pardini, Vespasiano, MG, Brasil.

Setor de Microbiologia. Núcleo Técnico Operacional.

Downloads

Published

2019-02-19

How to Cite

1.
Araújo MRB, Reis PV, Nascimento Bicalho PH, Seabra LF. Susceptibility of Streptococcus agalactiae to erythromycin and clindamycin in pregnant women in the prenatal screening. Clin Biomed Res [Internet]. 2019 Feb. 19 [cited 2025 Aug. 28];38(4). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/85574

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 > >> 

You may also start an advanced similarity search for this article.